Overview

This trial is active, not recruiting.

Condition ischemic stroke
Sponsor Medtronic Neurovascular Clinical Affairs
Start date August 2014
End date December 2017
Trial size 1000 participants
Trial identifier NCT02239640, NV-SFR005

Summary

The purpose of this registry is to assess outcomes associated with the use of devices intended to restore blood flow in patients experiencing acute ischemic stroke.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

Measure
Status of revascularization at the end of the interventional procedure
time frame: Day 0

Secondary Outcomes

Measure
Symptomatic intracranial hemorrhage
time frame: 90 days

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - An informed consent or waiver - Patient has experienced an acute ischemic stroke - Treatment within 8 hours of stroke onset Exclusion Criteria: - Concurrent participation in a randomized study

Additional Information

Official title Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
Principal investigator Nils Mueller-Kronast, M.D.
Description This is a registry evaluating the use of devices in patients diagnosed with an acute ischemic stroke. This registry may enroll up to 1000 patients.
Trial information was received from ClinicalTrials.gov and was last updated in August 2016.
Information provided to ClinicalTrials.gov by Medtronic Neurovascular Clinical Affairs.